ARCHIVES

UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says

This article is from The Cancer Letter archive.

Vol. 25 No. 36 | September 24, 1999

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities Listed.

January 14, 2005

Funding Opportunities

January 24, 2003

Gene Therapy Alters Immune Cells For Treatment Of Advanced Melanoma

September 29, 2006

Eight applications Received For NSABP chairman

September 9, 1994

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014

Did The Dog Eat It? NIH Fails To Turn In A Prostate Cancer Plan Assigned By Senate

April 23, 1999